GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These weight loss injections, GLP-1s like Wegovy, (same drug as Ozempic ...